InGeneron, Inc., a biotechnology company pioneering autologous regenerative cell therapies, today announced receipt of a CE Certificate (No. 28620235524 issued January 19, 2026) for the Transpose ...
Under the leadership of our hospital president and chief operating officer, Kevin Whitney, Cooley Dickinson remains committed ...